Vaccine News and Research

Latest Vaccine News and Research

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Vaccinating large populations of white-footed mice against the bacterium that causes Lyme disease could help reduce the risk of transmission of the disease to humans, says a study supported by the National Institute of Allergy and Infectious Diseases (NIAID).

14 Dec 2004

Safety of AIDS drug to prevent mother-to-child transmission of HIV questioned

In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry -- and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV

14 Dec 2004

Start today of human tests for a preventive vaccine against the respiratory disease SARS

Powerful research tools that speed up vaccine development have led to the start today of human tests for a preventive vaccine against the respiratory disease SARS. The disease killed hundreds of people around the world before it was brought under control in 2003 with aggressive conventional public health measures.

13 Dec 2004

Patent issued for generating genetically evolved mammalian cells through the regulation of mismatch repair

Morphotek announced today the issuance of United States Patent 6,825,038 covering the regulation of mismatch repair (MMR), a powerful process for generating functional diversity in mammalian cells, to yield sibs exhibiting desirable phenotypes for target discovery, drug screening and/or product development.

13 Dec 2004

Findings could lead to new knowledge that could speed the development of drugs to block botulism or tetanus toxins more rapidly

The first detailed structure of a botulism toxin attached to its target protein reveals that the toxin snakes the protein around itself — a sort of “reverse anaconda” — to recognize the receptor.

13 Dec 2004

Britain pledges four million doses of smallpox vaccine to a new global stockpile

Britain's Health Secretary John Reid today pledged to contribute four million doses of smallpox vaccine to a new global stockpile being assembled by the World Health Organisation.

13 Dec 2004

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

A team of researchers based partly in South Africa has identified a key set of immune system molecules that helps determine how effectively a person resists infection with human immunodeficiency virus (HIV).

8 Dec 2004

Chiron flu vaccine banned for a further three months

The Chiron Corporation, a vaccine manufacturer, were told today that the suspension of their licence for manufacturing influenza vaccine at the Speke factory in Liverpool, would continue for a further three months.

8 Dec 2004

HHS purchases 1.2 million doses of GSK's Fluarix flu vaccine

HHS Secretary Tommy G. Thompson has announced that the Food and Drug Administration authorized the use of GlaxoSmithKline influenza vaccine, Fluarix, in the United States under an Investigational New Drug application.

8 Dec 2004

ID Biomedical announces strategic alliances for U.S. marketing and distribution of Fluviral vaccine

ID Biomedical Corporation announced today that it has signed long term marketing, distribution and minimum purchase agreements with three of the largest influenza vaccine wholesalers in the United States: Henry Schein, Inc.; AmerisourceBergen Corporation's Specialty Group; and McKesson Corporation.

6 Dec 2004

Alliance to develop and commercialize fully-human anti-anthrax antibody

MDX-1303 was developed by Medarex using its UltiMAb Human Antibody Development System, and this antibody is currently in preclinical development by Medarex for use against human anthrax infection.

6 Dec 2004

Canadian experts gather to address emerging issues in immunization

More than 800 physicians, nurses, public health experts and researchers are gathering in Montreal this week for the sixth Canadian Immunization Conference, running Dec. 5-8, 2004. The conference is being hosted by the Public Health Agency of Canada and the Canadian Paediatric Society.

6 Dec 2004

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

Australian Medical Association Vice President, Dr Mukesh Haikerwal, has said the Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning.

6 Dec 2004

New technologies boost immunisation rates, safety

As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.

6 Dec 2004

Pennsylvania confirms first influenza case

Pennsylvania Health Secretary Dr. Calvin B. Johnson has announced that a 13-year-old Philadelphia County teen has the season's first, lab-confirmed case of flu.

4 Dec 2004

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Researchers at UT Southwestern Medical Center at Dallas have utilized an animal model to trace how the virus that causes AIDS in humans may enter and spread throughout the body following an oral exposure.

3 Dec 2004

Why our immune system worsens with age

Scientists at the Vaccine and Gene Therapy Institute at Oregon Health & Science University have made a discovery that helps explain why our immune system worsens with age. The work was led by Janko Nikolich-Zugich, M.D., Ph.D., a senior scientist at the VGTI.

2 Dec 2004

Potential vaccine for the deadly toxin ricin

A potential vaccine for the deadly toxin ricin, a "Category B" biological agent, will enter the first phase of clinical testing in coming weeks at UT Southwestern Medical Center at Dallas.

30 Nov 2004

Type 1 diabetes could be prevented by a new nasal insulin vaccine

A world-leading medical trial conducted in Melbourne suggests that the onset of type 1 diabetes could be prevented in many at-risk people by a new nasal insulin vaccine.

29 Nov 2004

Joint collaboration to fight avian influenza

Recognizing the pandemic potential and the threat to public health posed by the Avian Influenza, Health Ministers and senior officials of thirteen countries from Southeast and East Asian countries have pledged to accelerate joint collaboration in fighting the disease.

29 Nov 2004

Vaccine News and Research

Latest Vaccine News and Research

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Safety of AIDS drug to prevent mother-to-child transmission of HIV questioned

Start today of human tests for a preventive vaccine against the respiratory disease SARS

Patent issued for generating genetically evolved mammalian cells through the regulation of mismatch repair

Findings could lead to new knowledge that could speed the development of drugs to block botulism or tetanus toxins more rapidly

Britain pledges four million doses of smallpox vaccine to a new global stockpile

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

Chiron flu vaccine banned for a further three months

HHS purchases 1.2 million doses of GSK's Fluarix flu vaccine

ID Biomedical announces strategic alliances for U.S. marketing and distribution of Fluviral vaccine

Alliance to develop and commercialize fully-human anti-anthrax antibody

Canadian experts gather to address emerging issues in immunization

Australian Government's decision to purchase sufficient influenza vaccine for the next three seasons is good health planning

New technologies boost immunisation rates, safety

Pennsylvania confirms first influenza case

Animal model helps explain how AIDS virus spreads throughout the body following oral exposure

Why our immune system worsens with age

Potential vaccine for the deadly toxin ricin

Type 1 diabetes could be prevented by a new nasal insulin vaccine

Joint collaboration to fight avian influenza

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in